Park Ha Biological raises $2.97M in PIPE
BYAH raised approximately $2.97 million in a Regulation S PIPE with attached five-year warrants to non-U.S. investors.
Rhea-AI Filing Summary
Park Ha Biological Technology Co., Ltd. (BYAH) completed a Regulation S private investment in public equity (PIPE), selling 1,080,000 Class A ordinary shares at $2.75 per share to non-U.S. investors for aggregate gross proceeds of about $2,970,000 before expenses. Purchasers also received warrants to purchase 1,845,452 Class A ordinary shares, exercisable immediately for five years at an exercise price of $1.10 per share, with each warrant exercisable for two and one half Class A ordinary shares and subject to customary anti-dilution adjustments. The transaction closed on September 11, 2026, and the company intends to use net proceeds for general working capital and corporate purposes. The securities were issued in offshore transactions under Regulation S and are restricted from transfer to U.S. persons absent registration or an applicable exemption.
Positive
- None.
Negative
- None.
Key Figures
Shares sold: 1,080,000 Class A ordinary shares
Share purchase price: $2.75 per Class A ordinary share
Gross proceeds: $2,970,000
+5 more
8 metrics
Shares sold
1,080,000 Class A ordinary shares
Sold in the PIPE transaction to non-U.S. investors
Share purchase price
$2.75 per Class A ordinary share
Price in the PIPE transaction
Gross proceeds
$2,970,000
Aggregate gross proceeds from the PIPE before expenses
Warrant shares
1,845,452 Class A ordinary shares
Maximum Class A ordinary shares issuable upon exercise of warrants
Warrant exercise price
$1.10 per Warrant Share
Exercise price of the warrants issued in the PIPE
Warrant term
5 years
Term of the warrants from date of issuance
Closing date
September 11, 2026
Date the PIPE transaction closed
Par value
$0.008 per Class A ordinary share
Par value of the Class A ordinary shares issued
Key Terms
private investment in public equity, Regulation S, anti-dilution provisions, distribution compliance period, +1 more
5 terms
private investment in public equity financial
"Class A ordinary shares through a private investment in public equity"
Private investment in public equity occurs when investors buy shares directly from a company that is publicly traded, often at an early stage or at a discount, instead of purchasing them on the open market. This allows investors to acquire a stake more quickly and with potentially better terms, which can influence the company's future growth and stability—making it an important option for those seeking to support or benefit from a company's development.
Regulation S regulatory
"offered and sold in offshore transactions to non-U.S. persons in reliance upon Regulation S"
Regulation S is a set of rules that allows companies to sell securities (like shares or bonds) to investors outside the United States without having to follow all U.S. securities laws. It matters because it makes it easier for companies to raise money from international investors while still complying with U.S. regulations.
anti-dilution provisions financial
"The Warrants are subject to customary anti-dilution provisions reflecting share dividends"
Anti-dilution provisions are contract terms that protect an investor’s percentage ownership when a company issues new shares at a lower price than the investor originally paid. They work like an automatic recalculation of split pieces when a pie gets cut into more slices, preserving the investor’s relative stake and reducing unexpected losses of ownership and voting power, which matters because it affects potential control, future returns, and valuation of an investment.
distribution compliance period regulatory
"During the applicable distribution compliance period under Regulation S, the securities may not be offered"
warrants financial
"Purchasers of Class A Ordinary Shares in this PIPE will also receive warrants to purchase"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
Offering Details
private placement PIPE
Offering
Offering Type
private placement PIPE
Use of Proceeds
General working capital and corporate purposes
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What capital did BYAH raise in the September 2026 PIPE transaction?
Park Ha Biological Technology Co., Ltd. raised approximately $2,970,000 in gross proceeds by selling 1,080,000 Class A ordinary shares at $2.75 per share to non-U.S. investors in a Regulation S PIPE that closed on September 11, 2026.
What securities were issued by BYAH in this PIPE offering?
The company issued 1,080,000 Class A ordinary shares and granted warrants to purchase 1,845,452 Class A ordinary shares. The shares have a par value of $0.008 each and were sold at $2.75 per share.
What are the key terms of the BYAH warrants issued in the PIPE?
The warrants are exercisable immediately, have a five-year term from issuance, and carry an exercise price of $1.10 per Warrant Share. Each warrant is exercisable for two and one half Class A ordinary shares and includes customary anti-dilution provisions.
How will BYAH use the proceeds from the PIPE financing?
Park Ha Biological Technology Co., Ltd. intends to use the net proceeds from the PIPE transaction for general working capital and corporate purposes, according to the company’s disclosure.
Were BYAH’s PIPE securities registered under the U.S. Securities Act?
No. The Class A Ordinary Shares, warrants, and warrant shares were not registered under the Securities Act. They were offered and sold in offshore transactions to non-U.S. persons in reliance on Regulation S, with transfer restrictions applicable to U.S. persons.
When did BYAH’s PIPE transaction close and who bought the securities?
The PIPE transaction closed on September 11, 2026. The securities were purchased by certain non-U.S. investors in offshore transactions conducted in reliance on Regulation S.
AI-generated analysis. How Rhea-AI works. Not financial advice.
